Phase I/II trial of dose reduced capecitabine in elderly or frail patients with untreated advanced colorectal cancer.

被引：0
|
作者：
Breadner, Daniel Adam
Welch, Stephen
Jonker, Derek J.
Klimo, Paul
Cripps, M. Christine
Biagi, James Joseph
Lam, Wendy
Whiston, Frances
Stitt, Larry
Vincent, Mark David
机构：
[1] Schulich Sch Med & Dent, London, ON, Canada
[2] London Reg Canc Program, London, ON, Canada
[3] Ottawa Hosp, Res Inst, Ottawa, ON, Canada
[4] Continuum Med Care Ltd, W Vancouver, BC, Canada
[5] Ottawa Hosp, Ctr Canc, Ottawa, ON, Canada
[6] Canc Ctr Southeastern Ontario, Kingston, ON, Canada
[7] Burnaby Hosp, Reg Canc Ctr, Burnaby, BC, Canada
[8] London Hlth Sci Ctr, London, ON, Canada
[9] Univ Western Ontario, London, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 04期
关键词：
D O I：
10.1200/JCO.2017.35.4_suppl.745
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
745
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase I/II trial of dose-reduced capecitabine in elderly patients with advanced colorectal cancer
    Vincent, M. D.
    Breadner, D.
    Cripps, M. C.
    Jonker, D. J.
    Klimo, P.
    Biagi, J. J.
    Lam, W.
    O'Connell, A.
    Whiston, F.
    Stitt, L.
    Welch, S. A.
    CURRENT ONCOLOGY, 2017, 24 (04) : E261 - E268
  • [2] A phase II trial of Capecitabine (X) and Irinotecan (I) in a biweekly schedule in patients with untreated advanced colorectal cancer (ACRC)
    Garcia-Alfonso, P.
    Perez MAnga, G.
    Gonzalez, M. C.
    Lopez, P.
    Gonzalez, E.
    Belon, J.
    Molina, M.
    Pachon, V.
    Iglesias, L.
    Siso, I.
    EJC SUPPLEMENTS, 2005, 3 (02): : 181 - 181
  • [3] Health related quality of life in elderly or frail patients with advanced colorectal cancer treated with dose reduced capecitabine.
    Breadner, Daniel Adam
    Vincent, Mark David
    Jonker, Derek J.
    Cripps, M. Christine
    Klimo, Paul
    Biagi, James Joseph
    Lam, Wendy
    O'Connell, Anne
    Whiston, Frances
    Stitt, Larry
    Welch, Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] Capecitabine and oxaliplatin: A phase II study with a new schedule of administration in elderly patients with advanced colorectal cancer.
    Comandone, A
    Pochettino, P
    Bergnolo, P
    Boglione, A
    Dal Canton, O
    Cutin, SC
    Garetto, F
    Biscardi, M
    Oliva, C
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 291S - 291S
  • [5] Phase II Trial of Erlotinib and Capecitabine for Patients with Previously Untreated Metastatic Colorectal Cancer
    Kozuch, Peter
    Malamud, Steve
    Wasserman, Carrie
    Homel, Peter
    Mirzoyev, Takhir
    Grossbard, Michael
    CLINICAL COLORECTAL CANCER, 2009, 8 (01) : 38 - 42
  • [6] A phase II trial of capecitabine in previously untreated patients with advanced and/or metastatic gastric cancer
    Hong, YS
    Song, SY
    Lee, SI
    Chung, HC
    Choi, SH
    Noh, SH
    Park, JN
    Han, JY
    Kang, JH
    Lee, KS
    Cho, JY
    ANNALS OF ONCOLOGY, 2004, 15 (09) : 1344 - 1347
  • [7] Prospective phase II trial of pazopanib plus CapeOX (capecitabine and oxaliplatin) in previously untreated patients with advanced gastric cancer.
    Lee, Min-Young
    Kim, Seung Tae
    Lee, Jeeyun
    Park, Se Hoon
    Park, Young Suk
    Lim, Ho Yeong
    Kang, Won Ki
    Park, Joon Oh
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [8] Phase II trial of irinotecan and capecitabine in patients with advanced colorectal cancer (ACRC)
    Ahn, JB
    Jung, KH
    Park, YS
    Kim, YH
    Chang, HJ
    Sohn, DK
    Lim, SB
    Choi, HS
    Jeong, SY
    Park, JG
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 299S - 299S
  • [9] Health related quality of life in older or frail patients with advanced colorectal cancer treated with dose reduced capecitabine
    Breadner, Daniel
    Vincent, Mark David
    Jonker, Derek
    Cripps, Christine
    Klimo, Paul
    Biagi, James
    Lam, Wendy
    O'Connell, Anne
    Whiston, Frances
    Stitt, Larry
    Welch, Stephen
    JOURNAL OF GERIATRIC ONCOLOGY, 2018, 9 (06) : 659 - 664
  • [10] Phase II study of capecitabine, irinotecan, and celecoxib in advanced colorectal cancer.
    El-Rayes, BF
    Shields, AF
    Vaishampayan, U
    Heilbrun, L
    Bekaii-Saab, T
    Zalupski, MM
    Philip, PA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 310S - 310S
12345